Search For "zydus"
PM Modi concludes Zydus Biotech Park visit, next stop Bharat Biotech facil
Updated : 5 years, 5 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday concluded his visit to Zydus Biotech Park in Ahmedabad after reviewing the development of COVID-19 vaccine candidate ZyCOV-D.
Read More
PM Modi visits Zydus Biotech Park in Ahmedabad
Updated : 5 years, 5 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday arrived in Ahmedabad and proceeded to Zydus Biotech Park of the pharma major Zydus Cadila to review the vaccine development.
Read More
PM Modi to visit vaccine making units in Ahmedabad, Hyderabad, Pune today
Updated : 5 years, 5 months ago IST
New Delhi [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday will embark on a three-city visit to personally review the vaccine development and manufacturing process.
Read More
Zydus Wellness raises Rs 650 cr through QIB route
Updated : 5 years, 7 months ago IST
Ahmedabad (Gujarat) [India], September 29 (ANI): FMCG major Zydus Wellness said on Tuesday it has raised Rs 649.97 crore by issuing equity shares to qualified institutional buyers (QIBs).
Read More
Three COVID-19 vaccines at clinical trial stage in India: ICMR DG
Updated : 5 years, 8 months ago IST
New Delhi [India], September 15 (ANI): Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday.
Read More
Two Indian vaccine candidates against COVID-19 in phase two trials: VK Pau
Updated : 5 years, 8 months ago IST
New Delhi [India], Aug 29 (ANI): Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two Indian COVID-19 vaccines in second phase trial, Niti Aayog member Dr Vinod K Paul said on Saturday.
Read More
At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India
Updated : 5 years, 9 months ago IST
Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market.
Read More
Zydus Wellness Q1 net profit up 11 pc at Rs 89 crore
Updated : 5 years, 9 months ago IST
Ahmedabad (Gujarat) [India], July 31 (ANI): Zydus Wellness said on Friday its net profit for the April to June quarter jumped by nearly 11 per cent at Rs 89 crore from Rs 80 crore in the corresponding quarter of previous year.
Read More
Zydus gets Mexican regulator nod to conduct clinical trials with Pegylated
Updated : 5 years, 10 months ago IST
Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to conduct clinical trials with its biological therapy 'Pegylated Interferon alpha-2b' for the treatm
Read More
Pharma giant Zydus Cadila initiates clinical study on 1,048 volunteers for
Updated : 5 years, 10 months ago IST
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
Read More
Zydus begins human trials for potential COVID-19 vaccine
Updated : 5 years, 10 months ago IST
Ahmedabad (Gujarat) [India], July 15 (ANI): Pharmaceutical major Zydus on Wednesday started human clinical trials of its plasmid DNA vaccine ZyCoV-D -- a potential COVID-19 vaccine.
Read More
Zydus gets Mexican regulator nod for Desidustat in test management of COVI
Updated : 5 years, 10 months ago IST
Ahmedabad (Gujarat) [India], July 6 (ANI): Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its one of its lead research candidate Desidustat to be tested in the management of COVID-1
Read More